DK1526848T3 - Opiod-receptorantagonister i transdermale systemer med buprenorphin - Google Patents

Opiod-receptorantagonister i transdermale systemer med buprenorphin

Info

Publication number
DK1526848T3
DK1526848T3 DK03775130T DK03775130T DK1526848T3 DK 1526848 T3 DK1526848 T3 DK 1526848T3 DK 03775130 T DK03775130 T DK 03775130T DK 03775130 T DK03775130 T DK 03775130T DK 1526848 T3 DK1526848 T3 DK 1526848T3
Authority
DK
Denmark
Prior art keywords
receptor antagonists
buprenorphine
transdermal systems
opiod receptor
opiod
Prior art date
Application number
DK03775130T
Other languages
Danish (da)
English (en)
Inventor
Johannes Bartholomaeus
Heinrich Kugelmann
Eric-Paul Paques
Original Assignee
Gruenenthal Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE2002137057 external-priority patent/DE10237057A1/de
Priority claimed from DE2002137056 external-priority patent/DE10237056A1/de
Application filed by Gruenenthal Gmbh filed Critical Gruenenthal Gmbh
Application granted granted Critical
Publication of DK1526848T3 publication Critical patent/DK1526848T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
DK03775130T 2002-08-09 2003-08-08 Opiod-receptorantagonister i transdermale systemer med buprenorphin DK1526848T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE2002137057 DE10237057A1 (de) 2002-08-09 2002-08-09 Opioid-Rezeptor-Antagonisten in Pflasterformulierungen
DE2002137056 DE10237056A1 (de) 2002-08-09 2002-08-09 Opiod-Rezeptor-Antagonisten in Transdermalen Systemen mit Buprenorphin
PCT/EP2003/008828 WO2004014336A2 (fr) 2002-08-09 2003-08-08 Antagonistes du recepteur opioide dans des systemes transdermiques a base de buprenorphine

Publications (1)

Publication Number Publication Date
DK1526848T3 true DK1526848T3 (da) 2007-10-22

Family

ID=31716605

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03775130T DK1526848T3 (da) 2002-08-09 2003-08-08 Opiod-receptorantagonister i transdermale systemer med buprenorphin

Country Status (9)

Country Link
EP (1) EP1526848B1 (fr)
AT (1) ATE367155T1 (fr)
AU (1) AU2003283055A1 (fr)
CY (1) CY1107739T1 (fr)
DE (1) DE50307717D1 (fr)
DK (1) DK1526848T3 (fr)
ES (1) ES2290512T3 (fr)
PT (1) PT1526848E (fr)
WO (1) WO2004014336A2 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1718258E (pt) * 2004-02-23 2009-06-16 Euro Celtique Sa Dispositivo de administração transdérmica de opióides com resistência ao abuso
DE102004019916A1 (de) * 2004-04-21 2005-11-17 Grünenthal GmbH Gegen Missbrauch gesichertes wirkstoffhaltiges Pflaster
DE102006054731B4 (de) 2006-11-21 2013-02-28 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System zur Verabreichung des Wirkstoffs Buprenorphin und Verwendung desselben in der Schmerztherapie
GB2447016A (en) * 2007-03-01 2008-09-03 Reckitt Benckiser Healthcare Buprenorphine/naloxone compositions
GB2447015A (en) * 2007-03-01 2008-09-03 Reckitt Benckiser Healthcare Analgesic composition comprising a specific ratio of buprenorphine and naltrexone
JP2011515495A (ja) * 2008-03-26 2011-05-19 オールトランツ インコーポレイティド オピエートアゴニスト及びアゴニスト−アンタゴニストの乱用抑制経皮製剤
EA201491164A1 (ru) * 2011-12-12 2014-10-30 ЭлТиЭс ЛОМАНН ТЕРАПИ-ЗЮСТЕМ АГ Трансдермальная система доставки
AP2015008920A0 (en) 2013-06-04 2015-12-31 Lohmann Therapie Syst Lts Transdermal delivery system

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3939376C1 (fr) * 1989-11-29 1991-05-08 Lts Lohmann Therapie-Systeme Gmbh & Co. Kg, 5450 Neuwied, De
DE69709646T2 (de) * 1996-03-12 2002-08-14 Alza Corp., Palo Alto Zusammensetzung und dosisform mit einem opioid-antagonisten
JPH1036265A (ja) * 1996-07-19 1998-02-10 Nitto Denko Corp ブプレノルフィン経皮吸収製剤
US5968547A (en) * 1997-02-24 1999-10-19 Euro-Celtique, S.A. Method of providing sustained analgesia with buprenorphine
US5900420A (en) * 1997-06-19 1999-05-04 Cole; William L. Method for treating chronic fatigue syndrome and fibromyalgia with buprenorphine

Also Published As

Publication number Publication date
DE50307717D1 (de) 2007-08-30
WO2004014336A3 (fr) 2004-12-09
EP1526848A2 (fr) 2005-05-04
AU2003283055A1 (en) 2004-02-25
EP1526848B1 (fr) 2007-07-18
ES2290512T3 (es) 2008-02-16
PT1526848E (pt) 2007-08-08
WO2004014336A2 (fr) 2004-02-19
ATE367155T1 (de) 2007-08-15
AU2003283055A8 (en) 2004-02-25
CY1107739T1 (el) 2013-04-18

Similar Documents

Publication Publication Date Title
ATE388707T1 (de) Opioidantagonisthaltige zusammensetzung zur erhöhung der analgetischen wirksamkeit von tramadol und verringerung von ihre nebenwirkungen
WO2001066534A3 (fr) Antagonistes du recepteur d'histamine-3 diamino cycliques et bicycliques
AU2002350961A1 (en) Ethylene diamine derivatives and their use as orexin-receptor antagonists
GB0130347D0 (en) Compounds
CY1107739T1 (el) Ανταγωνιστες υποδοχεων οπιοειδων σε διαδερματικα συστηματα με μπουπρενορφινη
UY27720A1 (es) Aroilpiridinonas monocíclicas,
BRPI0510170B8 (pt) composto, composição farmacêutica para o tratamento de doenças mediadas pelo receptor muscarínico de acetilcolina e uso do composto
NO20052739D0 (no) CCR5-antagonister som medikamenter
NO983431D0 (no) Anti-kl°emidler
ATE430747T1 (de) 2-pyrimidinyl-pyrazolopyridin-erbb- kinaseinhibitoren
AU2003272285A8 (en) Thienopyrrolyl and furanopyrrolyl compounds and their use as histamine h4 receptor ligands
ATE384050T1 (de) Benzazepinderivate als histamin-h3-antagonisten
PT1379520E (pt) Antagonistas (nao-aril)-heterociclicos n-substituidos de nmda/nr2b
AU2003242544A1 (en) New indolylpiperidine derivatives as potent antihistaminic and antiallergic agents
BRPI0605921B8 (pt) compostos orgânicos, seus métodos de preparo e uso, bem como composições farmacêuticas
BRPI0415709A (pt) esquemas terapêuticos para antagonistas de baff
ATE399770T1 (de) Tachykininrezeptorantagonisten
ATE418548T1 (de) Substituierte 3-cyanothiophen acetamide als glucagon receptor antagonisten
SE0202598D0 (sv) Alpha-7 Nicotinic receptor agonists and statins in combination
DE602007012313D1 (de) Als a2b-adenosinrezeptorantagonisten geeignete 5-phenyl-6-pyridin-4-yl-1,3-dihydro-2h-imidazoä4,5-büpyridin-2-onderivate
TNSN07015A1 (en) Kynurenic acid amide derivatives as nr2b receptor antagonists
IS8377A (is) Arýlindenópyridín og arýlindenópyrimidín og notkun þeirra sem mótlyf A2A viðtaka adenósíns
WO2003082867A8 (fr) Derives d'azaindolylpiperidine comme agents antihistaminiques et antiallergiques
CY1109803T1 (el) Φαρμακευτικες συνθεσεις που βασιζονται σε ανταγωνιστες νκ2 για παιδιατρικη χρηση
TW200621785A (en) Analgesic